{"id":"https://openalex.org/W568633045","doi":"https://doi.org/10.1182/blood.v124.21.5341.5341","title":"Treatment of Adult Patients with the Modified Protocol of the International Consortium on Acute Promyelocitic Leukemia (IC-APL)","display_name":"Treatment of Adult Patients with the Modified Protocol of the International Consortium on Acute Promyelocitic Leukemia (IC-APL)","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W568633045","doi":"https://doi.org/10.1182/blood.v124.21.5341.5341","mag":"568633045"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.5341.5341","doi":"https://doi.org/10.1182/blood.v124.21.5341.5341","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.5341.5341","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110317452","display_name":"\u00c1lvaro Aguayo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097900","display_name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","ror":"https://ror.org/00xgvev73","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210097900","https://openalex.org/I4210128723"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Alvaro Aguayo","raw_affiliation_strings":["Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico, Mexico","institution_ids":["https://openalex.org/I4210097900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101579851","display_name":"Jorge Contreras","orcid":"https://orcid.org/0000-0002-7281-4228","observed_orcids":["https://orcid.org/0000-0002-7281-4228"]},"institutions":[{"id":"https://openalex.org/I4210097900","display_name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","ror":"https://ror.org/00xgvev73","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210097900","https://openalex.org/I4210128723"]}],"countries":["MX"],"is_corresponding":true,"raw_author_name":"Jorge Contreras Cisneros","raw_affiliation_strings":["Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico, Mexico","institution_ids":["https://openalex.org/I4210097900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057035296","display_name":"Adriana L\u00f3pez Rosas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097900","display_name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","ror":"https://ror.org/00xgvev73","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210097900","https://openalex.org/I4210128723"]}],"countries":["MX"],"is_corresponding":true,"raw_author_name":"Adriana Lopez Rosas","raw_affiliation_strings":["Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico, Mexico","institution_ids":["https://openalex.org/I4210097900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084278609","display_name":"Juan Mauricio Vera-Zertuche","orcid":"https://orcid.org/0000-0001-9477-6851","observed_orcids":["https://orcid.org/0000-0001-9477-6851"]},"institutions":[{"id":"https://openalex.org/I4210097900","display_name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","ror":"https://ror.org/00xgvev73","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210097900","https://openalex.org/I4210128723"]}],"countries":["MX"],"is_corresponding":true,"raw_author_name":"Juan Mauricio Vera Zertuche","raw_affiliation_strings":["Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico, Mexico","institution_ids":["https://openalex.org/I4210097900"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023668088","display_name":"Erick Crespo\u2010Sol\u00eds","orcid":"https://orcid.org/0000-0002-7437-1299","observed_orcids":["https://orcid.org/0000-0002-7437-1299"]},"institutions":[{"id":"https://openalex.org/I4210097900","display_name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","ror":"https://ror.org/00xgvev73","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210097900","https://openalex.org/I4210128723"]}],"countries":["MX"],"is_corresponding":true,"raw_author_name":"Erick Crespo Sol\u00eds","raw_affiliation_strings":["Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico, Mexico","institution_ids":["https://openalex.org/I4210097900"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5023668088","https://openalex.org/A5057035296","https://openalex.org/A5084278609","https://openalex.org/A5101579851"],"corresponding_institution_ids":["https://openalex.org/I4210097900"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"124","issue":"21","first_page":"5341","last_page":"5341"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-promyelocytic-leukemia","display_name":"acute promyelocytic leukemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pml-rara-rearrangement","display_name":"PML-RARA rearrangement","score":0.9169999957084656},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.8479999899864197},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.9430000185966492},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.6579999923706055},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.6930000185966492},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.6909999847412109},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.8410000205039978},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9670000076293945},{"id":"https://openalex.org/keywords/intrathecal-chemotherapy","display_name":"intrathecal chemotherapy","score":0.8009999990463257},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.5789999961853027},{"id":"https://openalex.org/keywords/disseminated-intravascular-coagulation","display_name":"disseminated intravascular coagulation","score":0.777999997138977}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7940144538879395},{"id":"https://openalex.org/C2779117419","wikidata":"https://www.wikidata.org/wiki/Q1063862","display_name":"Idarubicin","level":4,"score":0.7902959585189819},{"id":"https://openalex.org/C2776601000","wikidata":"https://www.wikidata.org/wiki/Q612108","display_name":"Acute promyelocytic leukemia","level":4,"score":0.7727891206741333},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.7282384037971497},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6018140912055969},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5236639380455017},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.48477429151535034},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.4773305058479309},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4669049382209778},{"id":"https://openalex.org/C2781021840","wikidata":"https://www.wikidata.org/wiki/Q411659","display_name":"Daunorubicin","level":3,"score":0.4380502700805664},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.4184098243713379},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3574032485485077},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.33020856976509094},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.2150801420211792},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v124.21.5341.5341","doi":"https://doi.org/10.1182/blood.v124.21.5341.5341","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.5341.5341","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2549401663","https://openalex.org/W4388464156","https://openalex.org/W2596520772","https://openalex.org/W2472693849","https://openalex.org/W120786735","https://openalex.org/W2125255848","https://openalex.org/W2550263022","https://openalex.org/W2023546573","https://openalex.org/W2588150640","https://openalex.org/W3158470921"],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"Acute":[2,61,114],"promyelocytic":[3],"leukemia":[4,23],"(APL)":[5],"with":[6,24,108,500,573],"PML/RARA":[7,367],"rearrangement":[8,368],"is":[9,565,585,608],"currently":[10],"classified":[11,310],"by":[12,353,373,463],"the":[13,18,57,86,94,113,118,156,159,176,191,216,239,292,366,376,476,486,544,566,574,578],"WHO":[14,161],"as":[15,276,311,561],"part":[16],"of":[17,20,51,56,73,88,91,96,106,117,120,150,158,274,283,289,300,328,360,388,412,436,451,467,492,526,570,594,605,614],"group":[19],"acute":[21],"myeloid":[22],"recurrent":[25],"genetic":[26],"abnormalities.":[27],"Therapeutic":[28],"improvements":[29],"in":[30,67,78,202,234,304,314,358,363,410,449,456,471,516,536,546,581],"chemotherapy":[31,168,201],"protocols":[32],"containing":[33],"trans-retinoic":[34],"acid":[35],"(ATRA)":[36],"have":[37],"achieved":[38,380,480],"complete":[39,74,381,457,472,481],"response":[40],"rates":[41,72,435],"close":[42],"to":[43,70,137,147,175,616],"90%":[44],"and":[45,76,85,122,162,198,211,227,281,313,362,399,421,426,432,439,523,543,602],"long-term":[46],"relapse":[47,513,607],"free":[48],"survival":[49,77,553,588],"curves":[50],"85%.":[52],"The":[53,165,247,269,345,434,490],"treatment":[54],"protocol":[55,84,178,576],"International":[58],"Consortium":[59],"on":[60,155],"Promyelocytic":[62],"Leukemia":[63,115],"(IC-APL),":[64],"which":[65,329,468],"started":[66],"2006,":[68],"sought":[69],"improve":[71],"remission":[75,383,459],"developing":[79],"countries":[80],"through":[81],"a":[82,331,386],"risk-based":[83],"implementation":[87],"daunorubicin":[89],"instead":[90],"idarubicin.":[92],"Recently":[93],"results":[95],"that":[97,262],"multicenter":[98],"study":[99],"were":[100,143,179,244,302,309,408,470,509],"published.":[101],"Methods":[102],"A":[103],"retrospective":[104],"cohort":[105],"patients":[107,142,204,241,290,306,322,361,413,455,478,571],"APL":[109,141,151],"was":[110,152,170,205,219,232,252,318,351,443,447,497,514],"studied":[111],"at":[112,196,250,325,385],"Clinic":[116],"Department":[119],"Hematology":[121],"Oncology,":[123],"Instituto":[124],"Nacional":[125],"de":[126],"Ciencias":[127],"M\u00e9dicas":[128],"y":[129],"Nutrici\u00f3n":[130],"Salvador":[131],"Zubir\u00e1n,":[132],"Mexico;":[133],"from":[134,145],"January":[135],"2007":[136],"June":[138],"2013.":[139,148,582],"All":[140],"recruited":[144],"2006":[146],"Diagnosis":[149],"established":[153],"based":[154],"recommendations":[157],"2000":[160],"subsequently":[163,524],"2008.":[164],"original":[166,177,579],"IC-APL":[167],"scheme":[169],"administered.":[171],"Some":[172],"minor":[173],"modifications":[174],"made:":[180],"we":[181,562],"did":[182],"not":[183,555,591],"search":[184],"for":[185,294,587,598],"minimal":[186,599],"residual":[187,600],"disease":[188,527,547,601],"neither":[189],"identify":[190],"PML":[192],"/":[193],"RARA":[194],"isoforms":[195],"diagnosis":[197,251,287],"prophylactic":[199],"intrathecal":[200],"high-risk":[203],"applied":[206],"(4-6":[207],"dose":[208],"cytarabine":[209],"60mg":[210],"methotrexate":[212],"12.5mg),":[213],"monthly,":[214],"once":[215],"consolidation":[217,488,496,507],"therapy":[218,226],"finished.":[220],"Patients":[221],"who":[222,479],"relapsed":[223],"received":[224,484],"rescue":[225],"autologous":[228,521],"HCT.":[229],"Allogeneic":[230],"HCT":[231,522,550],"performed":[233],"advaced":[235],"stages.":[236],"Results":[237],"Of":[238,375,529],"18":[240,377],"evaluated":[242],"11":[243],"women":[245],"(61.1%).":[246],"median":[248,387],"age":[249],"40":[253],"years,":[254],"(range":[255,391],"21-74":[256],"years).":[257],"It":[258],"should":[259],"be":[260,371,461],"noted":[261],"16.6%":[263],"had":[264,417,429],"more":[265],"than":[266],"65":[267],"years.":[268],"risk":[270],"classification":[271],"showed":[272],"27.8%":[273],"cases":[275],"low":[277],"risk,":[278],"55.6%":[279],"intermediate":[280],"16.7%":[282],"high":[284],"risk.":[285],"At":[286],"22.2%":[288,416,450],"met":[291],"criteria":[293],"disseminated":[295],"intravascular":[296],"coagulation.":[297],"Morphological":[298],"characteristics":[299],"BMA":[301],"analyzed;":[303],"17":[305,379,477],"(94.1%)":[307],"BMAs":[308],"classic":[312,332],"one":[315,364,427,535],"patient":[316,365,395,401,428,519],"it":[317],"considered":[319],"variant-type.":[320],"Sixteen":[321],"underwent":[323,520],"immunophenotyping":[324],"diagnosis,":[326],"100%":[327,469],"reported":[330,568],"pattern":[333],"immunophenotype":[334],"CD34":[335],"(-)":[336],"HLA-DR":[337],"(-),":[338],"CD13":[339],"(+)":[340],"CD33":[341],"(+),":[342],"myeloperoxidase":[343],"(+).":[344],"t":[346],"(15,":[347],"17)":[348],"(q22,":[349],"q21)":[350],"demonstrated":[352],"either":[354],"FISH":[355,464],"or":[356,465],"karyotype":[357],"94.4%":[359],"could":[369,460],"only":[370],"demostrated":[372],"PCR.":[374],"patients,":[378,531],"hematologic":[382,458],"(94.4%)":[384],"42":[389],"days":[390],"34-158":[392],"days).":[393],"One":[394],"died":[396,525,533],"during":[397,414,441,495,506],"induction":[398,442,541],"this":[400,564],"presented":[402],"multiple":[403],"comorbidities.":[404],"No":[405,504,611],"serious":[406],"complications":[407],"seen":[409],"66.7%":[411],"induction,":[415],"grade":[418],"3-4":[419],"infection":[420],"11.1%":[422],"non-hematologic":[423],"adverse":[424],"events":[425],"subarachnoid":[430],"hemorrhage":[431],"vasculitis.":[433],"severe":[437],"neutropenia":[438,494],"fever":[440],"61.1%.":[444],"ATRA":[445],"syndrome":[446],"identified":[448],"patients.":[452],"Only":[453],"15":[454],"analyzed":[462],"cytogenetics,":[466],"cytogenetic":[473],"remission.":[474],"In":[475],"remission,":[482],"14":[483],"all":[485,530],"programmed":[487],"chemotherapy.":[489],"incidence":[491],"febrile":[493],"29.4%,":[498],"contrasting":[499],"61.1%":[501],"after":[502,540,577],"induction.":[503],"deaths":[505],"phase":[508],"seen.":[510],"Bone":[511],"marrow":[512,538],"documented":[515],"5.9%.":[517],"This":[518],"progression.":[528],"two":[532],"(11.1%),":[534],"bone":[537],"aplasia":[539],"(5.5%)":[542],"other":[545],"progression":[548],"post-autologous":[549],"(5.5%).":[551],"Median":[552],"has":[554],"been":[556],"reached.":[557],"Conclusions":[558],"As":[559],"far":[560],"know":[563],"first":[567],"series":[569],"treated":[572],"modified-IC-APL":[575],"publication":[580],"Longer":[583],"follow-up":[584],"required":[586],"analysis":[589,597],"(median":[590],"reached).":[592],"Implementation":[593],"quantitative":[595],"RT-PCR":[596],"timely":[603],"detection":[604],"molecular":[606],"desirable.":[609],"Disclosures":[610],"relevant":[612],"conflicts":[613],"interest":[615],"declare.":[617]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}